Metabolic changes in heart homogenate of Syrian hamsters with hereditary cardiomyopathy (BIO 14.6 strain) were examined. Oxidation of labeled fatty acids and acetate by myopathic homogenates was severely depressed; CO 2 production from labeled acetate was only one-fifteenth of the control value, and butyrate oxidation was suppressed to one-fourth of the control value. Although the addition of carnitine enhanced the oxidation of palmitate and octanoate by homogenates from both healthy and cardiomyopathic hamsters, the magnitude of the depression of oxidation (60-80%) in the myopathic homogenates was not influenced by carnitine. No change occurred in the rate of formation of palmitoyl-CoA from palmitoyl-Z-carnitine or in the activity of acyl-CoA synthetases; similarly, the one- 14 C]acetyl-CoA by the myopathic homogenates was depressed to only 40% of the control values. The mechanism responsible for these defects in substrate oxidation by tissue homogenates from cardiomyopathic hearts has not been elucidated; however, significant increases in the activities of two of five hydrolytic enzymes indicate the possible involvement of lysosomes. Ventricular RNA and DNA, the ratio of RNA to DNA and the ratio of heart weight to body weight were all significantly increased, but myocardial water and triglyceride content and esterification of [l-14 CJpalmitate into neutral lipids showed no significant change. • The Syrian hamster with hereditary cardiomyopathy is a useful model for studying progressive, degenerative heart lesions under reproducible conditions (1). The clinical course of the cardiomyopathy and the hemodynamic and mechanical changes involved have been well documented (1-4). Morphological changes, especially development of myolytic foci and swelling of the mitochondria, are detectable as early as the age of 1 month in hamsters with the autosomal recessive gene; these changes are followed by an increase in the number and the size of mitochondria and an enlargement of the heart (1, 4, 5).
• The Syrian hamster with hereditary cardiomyopathy is a useful model for studying progressive, degenerative heart lesions under reproducible conditions (1) . The clinical course of the cardiomyopathy and the hemodynamic and mechanical changes involved have been well documented (1) (2) (3) (4) . Morphological changes, especially development of myolytic foci and swelling of the mitochondria, are detectable as early as the age of 1 month in hamsters with the autosomal recessive gene; these changes are followed by an increase in the number and the size of mitochondria and an enlargement of the heart (1, 4, 5) . Received May 31, 1973 . Accepted for publication January 25, 1974. 
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Although there have been numerous studies of this disease dealing with biochemical alterations, particularly in oxidative phosphorylation (6) (7) (8) and sarcoplasmic reticulum (9) (10) (11) , there have been few reports describing changes in intermediary metabolism of fatty acids. When dystrophic mice are used as the disease model, defective mitochondrial oxidation of [3- 14 C]pyruvate and [l- 14 C]palmitate (12) , a decreased carnitine acetyltransferase activity (13) , and low CoA content in skeletal muscle mitochondria (13) are found; all of these changes implicate dysfunction of the tricarboxylic acid cycle.
In studies of fatty acid oxidation and esterification by the myocardium (14) (15) (16) , severely depressed fatty acid and acetate oxidation by heart homogenates prepared from cardiomyopathic hamsters has been observed. This depression commences around the age of 2.5 months and is probably unrelated to /3-oxidation, carnitine palmitoyltransferase, and acyl-CoA synthetases.
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The addition of carnitine to the homogenates of diseased hearts does not markedly influence the relative magnitude of the depressed oxidation; this effect of carnitine is different from that seen with other types of cardiomyopathies (17, 18) and muscular dystrophies (12, 13, 19) .
Methods
Normal hamsters of the Syrian golden strain were obtained from the laboratory of the Food and Drug Directorate in Ottawa; hamsters of the BIO 14.6 strain were originally purchased from the Bio-Research Institute, Cambridge, Massachusetts, but they have been bred locally since 1969. The hamsters were housed individually in cages with wire mesh bottoms and fed laboratory chow and water ad libitum. They were killed at different ages (1-12 months) by decapitation; however, most experiments were performed on hamsters 2.5-6 months old for reasons presented in the Results. The heart was excised and immediately chilled in icecold physiological saline solution; a small portion of the heart was used for the determination of dry weight. Body weight and heart weight at the time of death were recorded. The heart was finely chopped with scissors in the cold solution; a 3% (w/v) homogenate was prepared in Krebs-phosphate buffer without CaCl 2 at pH 7.4 with a glass homogenizer and a Teflon pestle that rotated at 1,000 rpm for 90 seconds (15, 17) .
MEASUREMENT OF SUBSTRATE OXIDATION
The oxidation of various substrates was measured by a method described previously (15, 20) , although a wider range of oxidizable substrates was tested in this experiment. [l- 14 14 C]sodium butyrate used in these experiments were 200,000 counts/min in 1 (imo\e; the activity and amount of [l- 1 4 C]palmitoyl-CoA and [ l - 1 4 C ] a c e t y l -C o A were 200,000 counts/min in 0.46-0.12 //.moles. The manufacturer's specification of the purity of 14 C-palmitic acid was verified by gas chromatography (20) . All other radiochemicals were more than 97% pure. The labile substances-palmitoyl-CoA, acetyl-CoA, and palmitic acid-were used within 2 months to avoid decomposition caused by storage. Leftover l4 C-pyruvate in acidic buffer at pH 4.0 was discarded after 3 weeks because of the risk of its degradation to parapyruvate or acetate. All of the radiochemicals were purchased from the New England Nuclear Circulation Ratarch. Vol. XXXIV. April 1974 Corp., and other chemicals were purchased from Sigma Chemical Corp., Boehringer Mannheim Corp., or Fisher Scientific Corp.
In the experiments with palmitate or oleate, after the acid was pipetted into the main chamber of Warburg flasks with two sidearms, the flasks were flushed with 95% O 2 -5% CO 2 for more than 5 minutes, because this aeration reduced the blank value (15, 20) . The reaction mixture contained, in addition to the oxidizable labeled substrate, 8 /xmoles of adenosine triphosphate (ATP) and 0.12 /xmoles of CoA. In the palmitate or oleate experiments, 6 /imoles of sn-glycerol-3-phosphate (aglycerophosphate, l-glycerol-3-phosphate) and 4 nmoles of glutathione were also added. In all of the other experiments, 1.4 /xmoles of J-malic acid was included, because the supply of oxaloacetate is readily depleted under similar experimental conditions (21, 22) . Finally, most experiments were performed either in the presence or the absence of 2-4 jumoles of cH-carnitine, or in some cases, 2 /imoles of i-carnitine. The results were the same with either the dl-or the I-compound.
A small piece of filter paper was fitted in the center well of the Warburg flask; 1 ml of 1M KH 2 PO 4 was pipetted into one of the two sidearms and 1 ml of methanol was pipetted into the other. Finally, 1.5 ml of tissue homogenate was pipetted into the main chamber of the flask, and immediately thereafter all of the openings were closed. During this procedure, the flask was kept in an ice bath. The incubation was performed in a DubnofF metabolic shaker for 30 minutes at 37°C. At the end of the incubation period, the flasks were brought to the ice bath and tilted, thus transferring the methanol from the sidearm into the main chamber to stop the reaction. Subsequently, 0.1 ml of 10% KOH was injected into the center well through the rubber stopper of the flask. This injection was followed by a second tilting of the flask to pour the KH 2 PO 4 solution into the main chamber, thus bringing the pH of the incubation mixture to 4.5 (15, 20) . The flasks were incubated for another 30 minutes to complete the liberation of 14 CO 2 and its subsequent absorption by KOH. After the second incubation, the filter papers were transferred to individual counting vials. The center well was wiped dry with additional filter paper that was also put into the counting vial. After 10 ml of Bray's solution (23) was added to the vial, the radioactivity was determined by a scintillation spectrometer (Nuclear Chicago, Mark I); the efficiency was measured by a channels-ratio method. An average of 95% of the label was recovered from NaH 14 CO 3 after completion of the entire procedure. The 14 CO 2 activity in dpm was converted to content in /xmoles by dividing the former by the specific activity of the precursor, assuming that the latter did not significantly deviate during the experimental period.
A 0.5-ml sample of the homogenate was dissolved by warming in IN NaOH; this sample was then used for protein determination after appropriate dilution (24) . The results were expressed as /xmoles CO 2 produced/ml homogenate, /xmoles CO 2 produced/g ventricle, or /umoles/mg protein.
A preliminary study to determine the optimal conditions for fatty acid oxidation indicated that the addition of CoA and ATP accelerated the oxidation about twofold. Doubling the magnesium concentration did not influence the rate of oxidation. The presence of increasing amounts of di-carnitine up to a concentration of 2 mM raised palmitate oxidation. The oxidation of palmitate or palmitoyl-CoA was inhibited by 60% in the presence of 0.2 mM i-decanoylcarnitine. Similarly, various degrees of competitive inhibition were observed in the presence of nonradioactive acetate (3 mM), butyrate (1 mM), or octanoate (3.5 mM). Dilution of [l-
14 C]palmitate with nonlabeled palmitate resulted in a decrease in I4 CO 2 counts that was inversely proportional to the amounts of palmitate added.
With a tissue dilution of 6% (w/v), 14 CO 2 production was slightly nonlinear between 0.5 and 2.0 ml of homogenate, both in the presence and the absence of carnitine. However, the 3% tissue homogenates adopted in this study showed a direct correlation between the amount of tissue present and the output of 14 CO 2 in both control and diseased hearts. Moreover, the 14 CO 2 production was linear between 15 and 45 minutes of incubation under these conditions. The reaction was the same whether palmitate or oleate was used as the substrate. Potassium salts rather than albumin-bound fatty acids were used in the present study, since preliminary studies with short-and long-chain fatty acids (see Results) suggested that the experimental conditions which were adopted closely resembled the physiological situation in which very little free (unbound) fatty acid appears to exist in the extracellular and intracellular spaces.
ESTERIFIED FATTY ACIDS IN TISSUE
In the experiments in which the extent of fatty acid incorporation into tissue lipids or the tissue triglyceride • content was determined, the homogenate in the flask was quantitatively transferred to a centrifuge tube with several washings with a chloroform-methanol solution (1:1, v/v) (25) . Protein was spun down and lipids were extracted according to the procedure previously described (15, 16, 20) . Neutral lipids were separated by t h i n -l a y e r c h r o m a t o g r a p h y with a petroleum ether-ether-acetic acid solvent system (80:20:2, v/v/v) (16) . Spots were visualized by iodine vapor, scraped, and counted in a scintillator with Cab-O-Sil (4%, w/v) or Aquasol. The triglyceride concentration was determined by a modification of the method based on chromotropic acid formation after adsorption of phospholipids with Florisil (15).
ASSAY OF ACYL-CoA SYNTHETASE
Acyl-CoA synthetase (acid:CoA ligase-adenosine monophosphate [AMP], EC 6.2.1.2. and EC 6.2.1.3., and acetate:CoA ligase-AMP, EC 6.2.1.1.) was measured by the method based on hydroxamic acid formation (26) . Incubation was carried out for 1 hour in the presence of 1-2 mM potassium palmitate or 5-10 mM octanoate, butyrate, or acetate. Homogenates for this assay were prepared in 0.25M sucrose containing 0.01M Tris at pH 7.5 in a concentration of 6% (w/v); they were centrifuged at 1,000 g for 10 minutes to remove unbroken cells and fibrous materials. After some trial runs, it was apparent that the acyl-CoA synthetase was not the major factor responsible for the defective oxidative capacity of cardiomyopathic hamsters; therefore, more elaborate and sensitive assay methods (27) were not explored further.
ASSAY OF CARNITINE PALMITOYL TRANSFERASE
Carnitine palmitoyltransferase (EC 2.3.1.23.) of homogenates was assayed by a combined enzymatic method using phosphotransacetylase (EC 2.3.1.8.), carnitine acetyltransferase (EC 2.3.1.7.) and 5,5'-dithiobis-(2-nitrobenzoic acid) (28) . This assay included t h r e e stages. In the first stage, the carnitine palmitoyltransferase reaction was forced to proceed to the formation of palmitoyl-CoA and carnitine by the presence of an excess amount of palmitoyl-Z-carnitine (1.5/umoles in a final volume of 2.0 ml) and of CoA (2 fimoles). The reaction was linear for a short period only ( < 2 minutes). In the second incubation, the CoA remaining after the first reaction was converted to acetylCoA by newly added acetylphosphate (4 /xmoles in a total volume of 1.5 ml) and phosphotransacetylase. In the last stage, carnitine acetyltransferase was added to catalyze the formation of free CoA from the acetyl-CoA produced in the second reaction and the carnitine produced in the first reaction; the stoichiometrically released free CoA produced a color complex with 5,5'-dithiobis-(2-nitrobenzoic acid) (1 /xmole in 1.5 ml). The accuracy of this method was checked by using purified carnitine palmitoyltransferase (29) , which was standardized by measuring the rate of thioester bond formation in the presence of 1.6 /nmoles of CoA and 1.5 //.moles of palmitoyl-i-carnitine in a total volume of 1.5 ml (29) .
SUCCINIC DEHYDROQENASE ASSAY
Succinic dehydrogenase (succinate:oxidoreductase, EC 1.3.99.1.) of homogenates was assayed by a method (30) in which phenazine methosulfate and p-iodonitrotetrazolium violet were used as the electron acceptor and the color indicator, respectively; the development of the color was followed by a spectrophotometer (Unicam SP800) at a constant temperature (37°C). The results were expressed as the optical density change per milligram of protein in the homogenate. A pair of samples obtained from healthy and diseased hamsters was always run simultaneously, because the standardization in absolute units of the optical assay method of this enzyme is inaccurate. homogenates in the presence of 0.1% Triton X-100. Acid proteinase activity was measured according to a modification of the method of Anson (31) . Twicecrystallized bovine hemoglobin was used as the substrate, and the incubation was terminated at 2 and 10 minutes by the addition of 2 ml of 5% trichloroacetic acid. The amount of tyrosine equivalents in the supernatant solution was determined by using the FolinCiocalteau reagent (31, 32) . /3-Glucuronidase activity was determined with phenolphthalein glucuronide as the substrate (33) . The incubation was carried out for 2 hours at 37°C in a total volume of 1.0 ml.
ASSAYS OF HYDROLYTIC ENZYME ACTIVITIES
The acetylglucosaminidase assay was performed using a modification of the method of Sellinger et al. (32) with 3.3 mM p-nitrophenyl-N-acetyl-/3-D-glucosaminide as the substrate; the reaction was stopped after 30 minutes and the pH of the supernatant solution was brought to 11. The amount of liberated p-nitrophenol was determined by reading the extinction at 400 nm. The p-nitrophenylphosphatase activity was measured using 5.5 mM p-nitrophenylphosphate as the substrate in a 0.2M acetate buffer at pH 4.5 (32) . After incubation at 37°C for 10 minutes, the released p-nitrophenol was quantified colorimetrically as described earlier in this paper.
ACID PROTEOLYSIS MEASUREMENTS
The autolytic activities of muscle in an acid solution were also measured, because this assay has the advantage of using endogenous muscle proteins as the substrates of the endogenous proteolytic enzymes (34). Thus 2-5-ml samples of the homogenates were added to the 0.2M acetate buffer to bring the pH down to 5.0. The incubation was continued for 2-4 hours at 37°C, and thereafter the reaction was terminated by the addition of 10% trichloroacetic acid. A sample of the supernatant solution was used to determine its amino group content with the ninhydrin procedure using a 4M acetate buffer. Tyrosine was used as the standard, and zero-time values were used as blanks (34) .
ADENOSINE TRIPHOSPHATASE ASSAY
So-called myofibrillar adenosinetriphosphatase (ATPase) was assayed by a modification of a procedure described previously (35) . The heart was homogenized in 30 volumes of 0.32M sucrose. The fraction that was precipitated between 50 g (2 minutes) and 1,000 g (15 minutes) was used as the crude myofibrillar fraction for this assay. The preparation was examined with a phasecontrast microscope. The incubation was carried out for 3 minutes in a mixture composed of 0.1 mM CaC^, 5 mM NaN 3 , 6.25 mM ATP, and 177 mM Tris buffer at pH 7.42 in a total volume of 1.6 ml. The amount of released inorganic phosphate was determined by the Fiske-Subbarrow method (35) .
DMA AND RNA DETERMINATIONS
Amounts of RNA and DNA in homogenates were determined as described previously (36) ; the method Circulation Raearch, VoL XXXIV, April 1974 used was the modification by Munro and Fleck (37) of that developed by Schmidt and Tannhauser.
Results
The oxidation of exogenous acetate and butyrate by tissue homogenates prepared from hearts of cardiomyopathic hamsters was severely depressed (Fig. 1) . These and other metabolic changes app e a r e d around the age of 2.5 months, and thereafter the severity of the changes was unrelated to age. Acetate oxidation was depressed to one-fifteenth and butyrate oxidation was depressed to one-fourth of that of the control hamsters. were uninfluenced by the presence or the absence of carnitine (Fig. 1) .
The depressed 14 CO 2 production by heart homogenates of cardiomyopathic hamsters was also observed when labeled octanoate or palmitate was used as the oxidizable substrate (Fig. 2) . The addition of 2 mM dZ-carnitine to the incubation medium increased the rate of fatty acid oxidation twofold when octanoate was the substrate or ninefold when palmitate was the substrate over the rates recorded in the absence of carnitine both in healthy and myopathic hearts. However, regardless of the 
. The measurements were performed in the presence (+) and the absence (-) of carnitine. Open columns represent control values and stippled columns represent the values obtained with homogenates of diseased hearts. The bars indicate SE. The number of experiments was 9 (octanoate) and 12 (palmitate).
presence or the absence of this substance, octanoate oxidation was depressed by 59-69% and palmitate oxidation was depressed by 72-77% (Fig. 2) ; thus, the extent of the percent decrease in butyrate and palmitate oxidation was similar, suggesting that carnitine acyltransferase and lack of carnitine are not involved in the depression of oxidation.
When expressed in absolute terms, palmitate oxidation (3.57 nmoles/mg protein 30 min" 1 ) by the heart homogenate of hamsters was approximately one-fourth of butyrate oxidation (14-16 nmoles/mg 30 min" 1 ) (Figs. 1 and 2) ; these values agree with the compounds' carbon stoichiometry. On the other hand, our control value of palmitate oxidation (0.12 nmoles/mg min" 1 ) in the presence of carnitine was lower than that reported for rat heart homogenates (0.23-0.41 nmoles/mg min" 1 ) (39) but was slightly higher than that found in guinea pig heart homogenates (17, 18) .
The oxidation of [l-14 C]palmitoyl-CoA was examined on two occasions; it was depressed 35% in cardiomyopathic hearts. However, this experiment was not continued further, because of the existence of palmitoyl-CoA hydrolase (deacylase, EC 3.1.2.2.) and the complexity involved in using this surface-active, micelle-forming substance in a physiological manner (40) .
In an attempt to localize the metabolic defect existing in homogenates prepared from hamsters with hereditary myopathy, the oxidation of several tricarboxylic acid cycle intermediates was examined. Figure 3 shows the results obtained from the measurements of CO 2 [2, 3- 14 C] succinate, and [l- 14 C] acetyl-CoA. The oxidation of the tricarboxylic acid cycle intermediates was depressed approximately 50%. The method used did not attempt to calculate the flux at various steps of the cycle, since all the exogenous intermediates were not only diluted by endogenous metabolites but also they could transaminate and move across the mitochondrial membrane through the shuttle pathways (22, 41) . Theoretically, [2, 3- 14 C]succinate must complete cycling through the tricarboxylic acid cycle at least twice before it can produce labeled CO 2> whereas [l, 4- 14 C]succinate has to complete only one cycle. Accordingly, [2, 3- 14 C] succinate oxidation should have been depressed more than [l, 4- 14 C]succinate oxidation, if tricarboxylic acid cycle operation was singularly defective in cardiomyopathy. As shown in Figure 3 , however, the relative magnitude of the depressed oxidation of the two substrates nmoles/30min. was similar (43-46%).
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The difference in pyruvate oxidation between the control and the diseased hearts was of borderline significance (P< 0.025, N = 11), suggesting that carbohydrate metabolism in these hamsters is probably less affected. Such a difference in fat and carbohydrate metabolism in the pathological myocardium has been observed by others under different experimental conditions (6, 17, 18, 42) . Acetyl-CoA oxidation measured in the presence of carnitine was suppressed to various degrees (Fig.  3) , probably because of the rapid turnover of this substance in the small intracellular pools (41) . Also, in isolated tissue the rate of acetyl-CoA oxidation in the presence of carnitine was approximately 50% of the rate of acetate oxidation (Figs. 1 and 3) pyruvate produced CO 2 at a rate of 89 nmoles/mg protein 30 min" 1 (N = 2 and N = 6, respectively) regardless of the source of the homogenates, unequivocally demonstrating that pyruvate and aketoglutarate dehydrogenase complexes are unimpaired, as are lipoic acid and CoA availability in the mitochondria. Similarly, the one-step oxidation of succinic dehydrogenase activity did not differ between the experimental and the control homogenates (Table 1) .
Carnitine palmitoyltransferase was assayed and the activity was found to be unaltered in the diseased hamsters (Table 1) , as illustrated by our data on 14 CO 2 production (Figs. 1 and 2) . Although carnitine acetyltransferase activity was not directly measured, the addition of purified carnitine acetyltransferase to the homogenate from cardiomyopathic hamsters in the presence of either acetyl-CoA and carnitine or acetate had no effect on substrate oxidation.
These results suggested that a defect in acylCoA synthetases could be the cause of these metabolic derangements. However, our assay of palmitoyl-CoA synthetase (not shown) and of octanoyl-, butyryl-, and acetyl-CoA synthetases showed no significant deviation from control (Table  1) . Since available evidence favors the existence of several synthetases (27) , all of these enzymes must be similarly affected to account for the observed metabolic alterations; therefore, an assumption that defective synthetases constitute the sole pathogenetic mechanism is unlikely.
Further support was obtained by the experiments in which the soluble fraction prepared by spinning the homogenate of healthy hearts (200,-000 g for 90 minutes) was added to the incubation mixture containing the homogenate from the cardiomyopathic hearts. The oxidation of labeled acetate in the presence of carnitine under these conditions was as low as that found in the absence of this supernatant fraction (N = 2), suggesting that acylCoA synthetases are not responsible for the existing metabolic derangements, since these enzymes exist not only in the mitochondria but also in the soluble fraction (27) .
A few additional experiments were performed to more definitively localize the metabolic defect in the homogenates of cardiomyopathic hearts. First, postmicrosomal supernatant solution was prepared by centrifuging (200,000 g for 90 minutes) heart homogenates of the hamsters with hereditary muscular dystrophy. The possible inhibitory effect of the supernatant solution on the oxidation of Values are expressed as means ± SE. The number of determinations is given in parentheses. All the assays were performed using tissue homogenates. [2- u C] pyruvate by homogenates of both healthy and diseased hearts was examined; the 14 CO 2 output did not change regardless of the presence or the absence of both acetate and camitine (290 vs. 275 nmoles/30 min control and 202 vs. 180 nmoles/30 min cardiomyopathy, N = 2).
The product-inhibition of acetyl-CoA synthetase by AMP or the ineffective removal of AMP by guanosine triphosphate (GTP):AMP phosphotransferase (43) was also investigated. Acetate oxidation was uninfluenced by the addition of 3 mM AMP or 3 mM a-ketoglutarate, although the control homogenate responded to the addition of aketoglutarate in a normal manner. Similarly, the addition of 4.5 mM adenosine diphosphate (ADP) to the homogenate of cardiomyopathic hearts was without effect (N = 2).
Competition between pyruvate and acetate as the oxidizable substrate showed different characteristics between the present experiment with homogenates and previous experiments with guinea pig heart mitochondria (21). Thus, the addition of acetate did not influence the U CO 2 production from labeled pyruvate in the control heart in this experiment. Similarly, the addition of acetate and the control soluble fraction, which is rich in acetyl-CoA synthetase (27) , to the homogenate respiring in the presence of [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]pyruvate did not influence the oxidation, suggesting again that acetate is not the preferential substrate in the hamster heart homogenates. The only substance that significantly increased the 14 CO 2 output from labeled acetate by homogenates of diseased hamsters was pyruvate. The addition of 4 mM pyruvate increased acetate oxidation from 15.8 to 64.0 nmoles/30 min (N = 5).
Cardiomyopathy is characterized by myolysis and an increase in lysosomes (5) . Protein degradation may be a biochemical manifestation of myolysis that initiates or accompanies cardiac hypertrophy (44) . Therefore, several enzymes associated with lysosomes were assayed ( Table 2) . Interestingly, of the five enzymatic activities assayed, three enzymes showed no change and two enzymes showed significant increases.
Cardiomegaly existed in diseased hamsters between the ages of 3 and 8 months; this finding agrees with those presented in previous reports (1, 4) . Due to the effect of sex-linked chromosomes, hearts of female hamsters were heavier than those of male hamsters. Table 3 demonstrates that the ratio of heart weight to body weight increased by 46% in females of comparable weights; the RNA content in the ventricles also increased, but the DNA content per ventricle and the RNA-DNA ratio changed less. On the other hand, there was no significant change in RNA and DNA per mg protein and RNA and DNA per g ventricle.
A slight but significant increase was observed in ATPase of the myofibrillar preparation isolated from cardiomyopathic hamsters (Table 4) . This result may partly be due to the calcium-independenf ATPase described recently (45) ; hence, a further investigation of the enzyme activity using purified myosin ATPase (46) prepared from cardiomyopathic hearts is necessary. It is unlikely, however, that our data are greatly influenced by the ATPases of other subcellular fractions which are either inhibited by azide or unchanged by hereditary cardiomyopathy (10, 11, 30) . Some morphological observations (5) have indicated that infiltration of lipochrome material occurs in cardiomyopathic hearts; however, the chemically determined tissue triglyceride content showed a tendency to decrease (Table 4) . Furthermore, there was no difference in the extent of esterification of [l-I4 C]palmitate to the tissue triglyceride fraction under the experimental conditions adopted ( Values are means ± SE. Number of determinations is given in parentheses. All of the increases were statistically significant (P < 0.01). "The ratios of heart weight to body weight of control hamsters were compared with those of cardiomyopathic hamsters of comparable body weights (control 120 ± 3 g vs. cardiomyopathic 121 ± 2 g).
TABLE 4 Protein and Triglyceride Concentrations, Dry Weights, ATPase,and Fatty Acid Esterification
Measurements
Control Cardiomyopathy
Protein concentration (mg/ml homogenate) Dry weight-wet weight ratio (%) Myofibrillar ATPase (/xmole/mg protein min" Values are means ± SE. Number of determinations is given in parentheses. Except in the ATPase assays, there was no statistically significant change in measurements.
"Esterification expressed as percent of the precursor activity added.
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idation and fatty infiltration (12, 43) . However, the chloroform extract of the tissue homogenates which had been incubated in the presence of [l, 2-14 C] acetate did not show greater counts in the experimental hearts than it did in the control hearts. The addition of 6.6 mM succinate to the same incubation mixture depressed control acetate oxidation to almost one-tenth the value without succinate; this finding supports the hypothesis that succinate accelerates fatty acid synthesis and reduces CO 2 output from exogenous acetate (47) . However, the addition of succinate did not influence acetate oxidation by homogenates of cardiomyopathic hamsters.
Discussion
In this study, an attempt was made to examine the mechanism of depressed oxidation of acetate, butyrate, octanoate, and palmitate by heart homogenates prepared from hamsters suffering from hereditary cardiomyopathy. Experiments were performed by using tissue homogenates, i.e., heterogeneous suspensions. Although defective oxidative function might be localized to the mitochondria, metabolic alterations in heart homogenates were explored, because mitochondrial function is tied to extramitochondrial metabolism through various pathways (22, 41, 48) ; furthermore, homogenates more closely resemble a physiological situation of the heart with abnormal, focal lesions. Caution must be exercised, however, in interpreting the results obtained, since control mechanisms existing in the homogenate, mitochondria, and the whole heart are not necessarily identical. Some possible causative mechanisms discussed below, therefore, apply only to the experimental conditions selected, and their relevance to the metabolic alteration in the in situ hearts of cardiomyopathic hamsters needs further investigation.
Our results of the carnitine palmitoyltransferase assay, together with those obtained from the experiments with labeled fatty acids in the presence of carnitine and the data on long-and short-chain fatty acid oxidation suggest that the carnitine transferase-Iinked transport mechanism probably is not responsible for the depressed oxidation observed. However, our enzyme assays indicate unchanged activities of only palmitoyltransferase II (backward reaction) (49, 50) ; therefore, there is a possibility of a decreased activity of transferase I (forward reaction) (51) under these conditions. However, a recent study from another laboratory (50) has suggested that transferase I is unlikely to be the rate-limiting factor for the transport of fatty acyl moieties across the mitochondrial membrane, at least, in the perfused rat heart preparation.
Since the measured activities of acyl-CoA synthetases revealed no sign of enzyme defect (Table  1) and since the V^, values of the enzymes far exceeded the required oxygen consumption of the heart (27, 42, 50) , factors which modify the enzyme activity were also examined. However, the effects of additions of succinate, AMP, or a-ketoglutarate suggest that these modifying factors cannot solely constitute the pathogenetic mechanism. Similarly, our results, especially those with acetate, seem to exclude defective /3-oxidation as a possible causative factor. Nevertheless, a description of more definitive biochemical alterations awaits further elucidation of the intracellular distribution of acylCoA and of complex interactions between the tricarboxylic acid cycle and fatty acid oxidation (41, 48, 50, 52) . Such interactions possibly cause different magnitudes of depression of fatty acid and acetate oxidation and of oxidation of tricarboxylic acid cycle intermediates (Figs. 1-3) .
The extent of tricarboxylic acid cycle involvement in pathologic mechanisms can not be assessed quantitatively from our experiments. The oxidation of a-ketoglutarate, which was presumably diluted through the intra-and extramitochondrial shuttles by glutamate, aspartate, and oxaloacetate (22, 41, 48) , was depressed less than was the oxidation of succinate (Fig. 3) . On the other hand, our data on [l- 14 C]pyruvate and [l- 14 C]a-ketoglutarate oxidation suggested that myopathic homogenates contained sufficient CoA. Furthermore, it is unlikely that the tricarboxylic acid cycle intermediates were depleted under these conditions, since it was recently reported (53) that amino acids derived from tissue proteins can replenish the cycle intermediates through transamination reactions; pyruvate is one of the intermediates in such pathways. Similar pathways probably helped to maintain pyruvate oxidation (Fig. 3) and, presumably, oxygen consumption of homogenates of myopathic hearts at relatively high levels compared with the control levels.
A possible control mechanism operating in homogenates of diseased hamsters can be formulated by postulating the existence of more than one pool of acetyl-CoA, as previously proposed (21, 54) . Thus, acetyl-CoA derived from pyruvate is localized in the cardiomyopathic mitochondria close to the citrate synthetase, enabling it to effectively counteract the inhibition by succinyl-CoA, a
